This is a randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and effectiveness of subcutaneous injections of the weight-loss medication AC2307 (davalintide). This Phase II clinical trial is currently recruiting patients between the ages of 18 and 65 who have a BMI over 27.
Read moreDear Dr. Borigini, I have been living with RA for about 8 years, diagnosed at age 25. I have been taking methotrexate and having good... Read more »
Parents of children with ADHD are frequently concerned about one of the major side effects of stimulant medication: loss of appetite.... Read more »
Question: tentonjj asked...I am now in my 3rd week out of the hospital treatment for severe depression and I am doing ok. I am taking... Read more »
There have been several times a member of the HealthCentral community has asked about the safety of taking a weight loss supplement (diet... Read more »
The UK's first large-scale study on the impact of weight-loss surgery for obesity has reported a large reduction in type 2 diabetes and... Read more »
Overweight Type 2 diabetics who have weight-loss surgery may be able to reduce or completely stop their diabetes medications, a new study suggests.... Read more »
Source: ADAM Encyclopedia
SurgerySurgical procedures for obesity may be appropriate for some dangerously obese people, and they may reduce heart problems and many of the risks... Read more »
i am trying to find out if any of the meds I am currently taking can cause sexual problems. I am taking Prilosec, Allegra and Nasonex. Dr. Owens at... Read more »
A two-year study of more than 3,000 obese people suggests that the obesity medication lorcaserin safely aids weight loss. The study found that nearly... Read more »
According to researchers, there is no way to know the long-term effects of weight-loss drugs. Medications such as Xenical, Meridia, and Acomplia have... Read more »